19
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Sequential Changes in Vitamin D and Calcium Metabolism after Successful Renal Transplantation

, , , , , , & show all
Pages 21-27 | Received 02 Nov 1992, Accepted 25 May 1993, Published online: 15 Feb 2010

REFERENCES

  • Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 1984; 74: 1540–1544.
  • Chetterjee SN, Friedler RM, Berne TV, Oldham SB, Singer FR, Massry SG. Persistent hypercalcemia after successful renal transplantation. Nephron 1976; 17: 1–7.
  • Cheung AK, Manolagas SC, Catherwood BD, Mosely CA, MitasII JA, Blantz RC, Deftos LJ. Determinants of serum 1,25(OH)2D levels in renal disease. Kidney Int 1983; 24: 104–109.
  • Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987; 325: 62–65.
  • Cundy T, Kanis JA, Heynen G, Morris PJ, Oliver DO. Calcium metabolism and hyperparathyroidism after renal transplantation. Q J Med 1983; 52: 67–78.
  • Dabek JT, Härkönen M, Adlercreutz H. A sensitive and simplified receptor assay for 1,25(OH)2 vitamin D. Scand J Clin Lab Invest 1981; 41: 151–158.
  • Delmas PD, Wilson DM, Mann KG, Riggs BL. Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab 1983; 57: 1028–1030.
  • Felsenfeld AJ, Gutman RA, Drezner M, Llach F. Hypophosphatemia in long-term renal transplant recipients: effect on bone histology and 1,25-dihydroxycholecalciferol. Mineral Electrolyte Metab 1986; 12: 333–341.
  • de Francisco AM, Riancho J, Amado JA, del Arco C, Macias JG, Cotorruelo JG, Arias M. Calcium, hyperparathyroidism, and vitamin D metabolism after kidney transplantation. Transplant Proc 1987; 19: 3721–3723.
  • Garabedian M, Holick MF, DeLuca HF, Boyle IT. Control of 25-hydroxycholecalciferol metabolism by the parathyroid glands. Proc Natl Acad Sci USA 1972; 69: 1673–1677.
  • Garabedian M, Silve C, Levy-Bentolila D, Bourdeau A, Ulmann A, Nguyen TM, Lieberherr M, Broyer M, Balsan S. Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children. Kidney Int 1981; 20: 403–410.
  • Gray RW, Wilz DR, Caldas AE, LemannJr J,. The importance of phosphate in regulating plasma 1,25(OH)2 vitamin D levels in humans: studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1977; 45: 299–305.
  • Graziani G, Castelnovo C, Aroldi A, Adami S, Viganó E, Casati S, De Vecchi A. Response of renal trnasplanted patients to oral calcium load. Nephrol Dial Transplant 1990; 5: 531–534.
  • Haddad JG, Walgate J. 25-hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem 1976; 251: 4803–4809.
  • Higgins RM, Richardson AJ, Endre ZH, Frostick SP, Morris PJ. Hypophosphatemia after renal transplantation: Relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy. Nephrol Dial Transplant 1990; 5: 62–68.
  • Julian BA, Laskow DA, Dubovsky J, Dubonvsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544–550.
  • Llach F, Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985; 61: 601–606.
  • Lucas PA, Woodhead JS, Brown RC. Vitamin D3 metabolites in chronic renal failure and after renal transplantation. Nephrol Dial Transplant 1988; 3: 70–76.
  • Lukert BP, Higgins JC, Stoskopf MM. Serum osteocalcin is increased in patients with hyperparathyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1986; 62: 1056–1058.
  • Lund B, Clausen E, Friedberg M, Lund B, Moszkowicz M, Nielsen SP, Sorensen OH. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Nephron 1980; 25: 30–33.
  • Malluche HH, Faugere M-C, Fanti P, Price PA. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984; 26: 869–874.
  • Mitlak BH, Alpert M, Lo C, Delmonico F, Neer RM. Parathyroid function in normocalcemia renal transplant recipients: Evaluation by calcium infusion. J Clin Endocrinol Metab 1991; 72: 350–355.
  • Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571–2577.
  • Nehme D, Rondeau E, Paillard F, Moreau JF, Nussaume O, Kenfer A, Sraer J-D. Aseptic necrosis of bone following renal transplantation: Relation with hyperparathyroidism. Nephrol Dial Transplant 1989; 4: 123–128.
  • Parfitt AM, Kleerekoper M, Cruz C. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: Implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Mineral Electrolyte Metab 1986; 12: 356–362.
  • Portale AA, Halloran MM, Morris RCJ. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 1986; 77: 7–12.
  • Reichel H, Deibert B, Schmidt-Gayk H, Ritz E. Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 1991; 6: 162–169.
  • Reinharth TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984; 58: 91–98.
  • Riancho JA, de Francisco ALM, del Arco C, Amado JA, Cotoruello JG, Arias M, Gonzales-Macias J. Serum levels of 1,25-dihydroxyvitamin D after renal transplantation. Mineral Electrolyte Metab 1988; 14: 332–337.
  • Rosenbaum RW, Hruska KA, Korkor A, Anderson C, Slatopolsky E. Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 1981; 19: 568–578.
  • Saha H, Pietilä K, Mustonen J, Pasternack A, Mörsky P. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients. Clin Nephrol 1992; 38: 145–148.
  • Saha H, Salmela K, Ahonen J, Pietilä K, Mörsky P, Pasternack A. Short-term effects of renal transplantation on the metabolism of vitamin D3. Transplant Proc 1992; 24: 367–368.
  • Sakhaee K, Brinker K, Helderman JH, Bengfort JL, Nicar MJ, Hull AR, Pak CYC. Disturbances in mineral metabolism after successful renal transplantation. Mineral Electrolyte Metab 1985; 11: 167–172.
  • Stein B, Halloran BP, Reinhardt T, Engstrom GW, Bales CW, Drezner MK, Currie KL, Takizawa M, Adams JS, Epstein S. Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. Endocrinology 1991; 128: 1369–1373.
  • Vezzoli G, Elli A, Palazzi T, Scabini M, Quarto di Palo F, Bianchi G. High plasma ionized calcium with normal PTH and total calcium levels in normal-function transplant recipients. Nephron 1986; 42: 290–294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.